- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HMGB1 as a drug target in staphylococcal pneumonia ; volume:18 ; number:2 ; day:31 ; month:3 ; year:2014 ; pages:1-3 ; date:4.2014
Critical care ; 18, Heft 2 (31.3.2014), 1-3, 4.2014
- Urheber
-
Fink, Mitchell P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/cc13810
- URN
-
urn:nbn:de:1111-201604239126
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fink, Mitchell P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia
An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms
Rapid and direct VHH and target identification by staphylococcal surface display libraries
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Staphylococcal peptidoglycans induce arthritis
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Staphylococcal and enterococcal immunomodulatory peptides
Wonderful drug for walking pneumonia: oseltamivir
Drug-drug relationship based on target information: application to drug target identification
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia
An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms
Rapid and direct VHH and target identification by staphylococcal surface display libraries
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Staphylococcal peptidoglycans induce arthritis
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Staphylococcal and enterococcal immunomodulatory peptides
Wonderful drug for walking pneumonia: oseltamivir
Drug-drug relationship based on target information: application to drug target identification
Identification of biomarker signatures for the discrimination of pneumococcal pneumonia from staphylococcal pneumonia
High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia
An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms
Rapid and direct VHH and target identification by staphylococcal surface display libraries
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Staphylococcal peptidoglycans induce arthritis
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Staphylococcal and enterococcal immunomodulatory peptides
Wonderful drug for walking pneumonia: oseltamivir